Join
Live feed
·
INSIDERFilingvia Quantisnow
Corcept Therapeutics Incorporated logo

Director Cannon Gillian gifted 7,393 shares, closing all direct ownership in the company (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CORT (Corcept Therapeutics Incorporated) and more on Quantisnow.